Professor Hyungjoon Cha is a leading biomaterials researcher who has been developing source materials through his original research on the world's only mussel-derived adhesion protein.
He secured the original technology using microbial cell culture. This technology is harmless to the human body and boasts excellent underwater adhesion and processability. It has been enhanced through continuous research. He was awarded the Hongjo Geunjeong Medal and Engineering Award for developing applied technologies in the fields of formulation technology and tissue engineering. Also, he selected as a key figure in the top 100 future technologies by the National Academy of Engineering of Korea.
He has developed and expanded technologies in the medical and pharmaceutical fields. These include surgical tissue adhesives, underwater adhesive sealants, microneedle adhesive patches, and adhesive nano/microparticle formulation drug delivery. He has also succeeded in mass-producing medical products through various uses and technology transfer.
He is the only person in the world who has commercialized technology that utilizes mussel adhesion proteins for medical products, and he is leading the field.
The extracutaneous soft tissue adhesive medical device is in clinical trials at a university hospital. The cartilage regeneration medical device has been approved by the Korea Food and Drug Administration and is scheduled for clinical trials.
Professor Cha's development of original materials from shellfish is regarded as a game changer in medical care, opening up endless possibilities for biomaterials. It is recognized as the most successful model in Korea's marine biotechnology field and has helped improve the quality of human life significantly.